About DVS Sciences
DVS Sciences is a Healthcare company based in San Francisco (United States) founded in 2004, and was acquired by Fluidigm in January 2014. Novel bioanalytical solutions are manufactured and distributed globally. DVS Sciences has raised $18.73 million across 2 funding rounds from investors including Pfizer, Fluidigm and Ontario Institute for Cancer Research. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified. Its competitors include Cepheid, Beckman Coulter and Blackrock Neurotech; 2 of its 3 listed competitors have raised funding.
Company details
DVS Sciences was founded in 2004 in San Francisco, United States. Bioanalytical solutions focused on life sciences are manufactured and distributed worldwide. Operations center on a patented multi-parameter system that includes the CyTOF mass cytometer for quantitative single-cell analysis and MAXPAR reagents featuring stable-isotope-tagged antibodies. Global reach supports research and analytical applications in biotechnology.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcare
- Website dvssciences.com
- Social X Facebook
- Acquired by Fluidigm (Jan 2014)
Funding Insights of DVS Sciences
DVS Sciences has successfully raised a total of $18.73M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14.6 million completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.73M
- Total Rounds 2
- Last Round Series A — $14.6M
- First Round $4.13M
(Feb 2011)
- Investors Count 5
All 2 funding rounds of DVS Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2011 | $14.6M | Series A | – | 5AM Ventures, Mohr Davidow Ventures | – |
| Feb 2011 | $4.13M | Series A | – | – | – |
6 investors in total: 6 institutional.
Investors in DVS Sciences
DVS Sciences has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Fluidigm and Ontario Institute for Cancer Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed incubator focused on the healthcare startups | 5amventures.com | San Francisco, United States | ||
Venture capital investments are managed in technology and healthcare sectors by this firm. | mdv.com | |||
Corporate-backed venture capital firm focused on the healthcare sector | roche.com/venturefund.htm | |||
Pharmaceutical products for treating multiple diseases are provided. | 1849 | pfizer.com | New York, United States | |
High-impact translational cancer research is conducted and enabled. | 2005 | oicr.on.ca | Toronto, Canada | |
Instruments for life sciences research and applications are developed. | 1999 | fluidigm.com | San Francisco, United States |
Investor details for DVS Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of DVS Sciences
4 dated milestones of DVS Sciences across 10 years, from founding to its latest funding, stage changes and deals.
- Founded DVS Sciences is founded.
- Funding First funding round of $4.1M.
- Funding Latest funding round, Series A, of $14.6M.
- Exit Acquired by Fluidigm.
Competitors of DVS Sciences
DVS Sciences has 3 listed competitors in our database, 2 of them funded. They include Cepheid, Beckman Coulter and Blackrock Neurotech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| beckman.com | 1935 | Brea, United States | Provider of products for biomedical testing for R&D, diagnostic and commercial applications | |||
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. |
Detailed competitors of DVS Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DVS Sciences
Websites that share an audience with DVS Sciences (dvssciences.com).
Websites whose visitors overlap most with DVS Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fluidigm.com | 86% | 1.1K | #14,860,207 | View details | |
| beckmancoulter.com | 74% | 113.9K | #341,469 | View details | |
| cytobank.org | 57% | 9.1K | #1,707,314 | View details | |
| antalis.com | 35% | 26.6K | #1,861,968 | View details | |
| dri.ie | 29% | 9.6K | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for DVS Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as DVS Sciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DVS Sciences
DVS Sciences was founded in 2004 and raised its 1st funding round 7 years after it was founded.
DVS Sciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
DVS Sciences is a funded company, having raised a total of $18.73M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.13M, raised on Feb 2011.
DVS Sciences was founded in 2004 in San Francisco, United States. Bioanalytical solutions focused on life sciences are manufactured and distributed worldwide. Operations center on a patented multi-parameter system that includes the CyTOF mass cytometer for quantitative single-cell analysis and MAXPAR reagents featuring stable-isotope-tagged antibodies. Global reach supports research and analytical applications in biotechnology.
DVS Sciences's top competitors include Cepheid, Blackrock Neurotech and Beckman Coulter.
DVS Sciences has 6 investors. Key investors include Pfizer, Fluidigm, Ontario Institute for Cancer Research, 5AM Ventures, and Mohr Davidow Ventures.
Yes. DVS Sciences was acquired by Fluidigm in January 2014.